Memantine Teva Sante (Memantine Hydrochloride)

Memantine works by blocking the NMDA‑type glutamate receptor in a non‑competitive manner. This reduces excessive calcium entry into neurons that occurs during prolonged glutamate stimulation, thereby limiting excitotoxic damage and supporting neuronal health, which can translate into better cognitive function in Alzheimer’s patients.

The specific dose of Memantine Teva Sante is determined by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks with their healthcare provider.

To request Memantine Teva Sante, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, whereas drugs such as donepezil, rivastigmine, and galantamine are cholinesterase inhibitors. Memantine targets excitotoxic pathways, while cholinesterase inhibitors enhance acetylcholine signaling. Both classes may be used together for complementary effects, but they have distinct mechanisms and side‑effect profiles.

Memantine Teva Sante tablets should be stored at temperatures below 25 °C, in their original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Memantine Teva Sante is taken orally, usually with or without food, as directed by a healthcare professional. The tablets are swallowed whole with a glass of water. Patients should not crush, chew, or split the tablets unless specifically instructed by their prescriber.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, seizures, and significant elevations in liver enzymes. Patients should seek immediate medical attention if they experience rash, difficulty breathing, persistent vomiting, or new neurological symptoms.

Memantine is contraindicated in patients with known hypersensitivity to memantine hydrochloride or any of the tablet’s excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and it should be avoided in pregnant or breastfeeding women unless clearly indicated by a physician.